
CVS Health has recently appointed four new board members, including the CEO of a hedge fund that has been critical of the company's performance. The decision to expand the board to 16 members came after discussions with shareholder Glenview Capital Management, which holds a 1% stake in the company.
Glenview Capital Management has expressed concerns about CVS Health operating below its potential, leading to multiple forecast cuts this year. Glenview's CEO, Larry Robbins, will now join the CVS Health board along with Guy Sansone, Chairman and CEO of H2 Health, Doug Shulman, Chairman of OneMain Holdings, and Leslie Norwalk, a former acting administrator with the Centers for Medicare and Medicaid Services.